10-Q: Richardson Electronics Q2 Sees Profit Turnaround
Quarterly Report
Richardson Electronics reported a significant turnaround in its six-month financial performance, moving from a net loss to a net income, driven by strong growth in Green Energy Solutions and Canvys segments.
Summary
- Net sales for the second quarter increased 5.7% to $52.3 million, and for the first six months, increased 3.6% to $106.9 million, compared to the prior year periods.
- The company achieved an operating income of $0.1 million for Q2 FY26, a significant improvement from an operating loss of $0.7 million in Q2 FY25.
- For the first six months of FY26, operating income was $1.1 million, compared to an operating loss of $0.4 million in the prior year.
- Net loss for Q2 FY26 was reduced to $0.1 million from $0.8 million in Q2 FY25.
- Net income for the first six months of FY26 was $1.8 million, a substantial improvement from a net loss of $0.2 million in the first six months of FY25.
- Green Energy Solutions (GES) segment sales surged by 39.0% in Q2 and 10.7% for the six months, primarily due to strong adoption of Power Management products.
- Canvys segment sales grew by 28.1% in Q2 and 17.7% for the six months, driven by higher sales in North American and European markets.
- Power and Microwave Technologies (PMT) segment sales decreased by 4.0% in Q2 and 0.5% for the six months, mainly due to declines in Electron Device and Healthcare products, partially offset by growth in RF and Microwave products.
- Selling, general and administrative expenses decreased slightly due to lower travel expenses, improving as a percentage of net sales for both periods.
- Cash and cash equivalents stood at $33.1 million as of November 29, 2025.
- The company extended its PNC Credit Agreement for three years, maturing October 7, 2028, with a maximum borrowing limit of $20 million, with no outstanding balance.
- A new General Ledger (GL) system was launched and adopted during the quarter, enhancing efficiency and simplifying accounting processes.
Sentiment
Score: 7
Explanation: The company demonstrated a significant turnaround in profitability for the six-month period, moving from a net loss to a net income, driven by strong growth in its Green Energy Solutions and Canvys segments. While the PMT segment saw a slight decline, overall sales increased, and operating expenses were managed effectively. The extension of the credit facility and implementation of a new GL system are also positive operational indicators. However, the decline in cash from operating activities and increased capital expenditures warrant attention.
Positives
- Significant improvement in operating results, moving from losses to income for both the quarter and six-month periods.
- Net income of $1.8 million for the first six months of fiscal 2026, compared to a net loss of $0.2 million in the prior year.
- Strong sales growth in Green Energy Solutions (GES) segment, up 39.0% in Q2 and 10.7% for the six months.
- Robust sales growth in Canvys segment, up 28.1% in Q2 and 17.7% for the six months.
- Reduced Selling, General and Administrative (SG&A) expenses as a percentage of net sales (30.5% in Q2 FY26 vs. 32.3% in Q2 FY25; 29.8% in 6M FY26 vs. 31.1% in 6M FY25).
- Extension of the $20 million Revolving Credit Facility for three years until October 7, 2028, with no outstanding balance, indicating strong liquidity and access to capital.
- Successful implementation of a new General Ledger system to enhance efficiency and simplify accounting.
- Increased interest income for both the three and six-month periods.
Negatives
- Net loss of $0.1 million for the second quarter of fiscal 2026, despite significant improvement from the prior year.
- Power and Microwave Technologies (PMT) segment experienced a sales decline of 4.0% in Q2 and 0.5% for the six months, primarily due to decreases in Electron Device and Healthcare products.
- Consolidated gross margin slightly decreased in Q2 (30.8% vs. 31.0%) due to product mix and lower manufacturing absorption in PMT and product mix in GES.
- Cash flows from operating activities decreased to $1.3 million for the first six months of fiscal 2026 from $5.9 million in the prior year.
- Cash used in investing activities increased to $2.6 million for the first six months of fiscal 2026 from $1.4 million in the prior year, driven by higher capital expenditures.
- Foreign exchange loss of $0.5 million in Q2 FY26 and $0.2 million for the six months.
Risks
- Economic pressures related to inflation, rising interest rates, economic weakness or recession.
- Geopolitical and public health issues, and pandemics.
- Tightening labor markets.
- Global business disruption caused by armed conflicts in Europe and the Middle East.
- Currency exchange fluctuations.
- Ability to manage growth.
- Impact of tariffs and other trade protection measures, which could dampen customer demand, increase market volatility, and affect currency exchange rates.
- Inability to successfully pass through additional costs of tariffs or reduced demand due to higher prices, negatively affecting sales and gross margins.
- Uncertainty regarding the realization of deferred tax assets, as indicated by the valuation allowance of $2.9 million.
Future Outlook
The company expects to continue manufacturing a limited quantity of ALTA CT X-ray tubes exclusively for DirectMed for approximately twelve months following the January 24, 2025 asset sale. Management believes existing liquidity sources will provide sufficient resources to meet known capital requirements and working capital needs through the next twelve months. The company is evaluating the future impact of the One Big Beautiful Bill Act (OBBBA) on its financial position, which makes 100% bonus depreciation and domestic research cost expensing permanent for fiscal years beginning after December 31, 2024.
Management Comments
- Our strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities.
- Management continues to work with its suppliers as well as its customers to mitigate the impact of the tariffs on our customers markets.
- Based on past performance and current expectations, we believe that the existing sources of liquidity, including current cash, will provide sufficient resources to meet known capital requirements and working capital needs through the next twelve months.
- We believe our existing sources of liquidity as well as our ability to generate operating cash flows will satisfy our future obligations and cash requirements.
Industry Context
The company operates in diverse markets including alternative energy, healthcare, aviation, and semiconductor. The strong growth in the Green Energy Solutions segment aligns with broader industry trends towards renewable energy and power management. The decline in traditional Electron Device and Healthcare products within PMT, despite the exclusive supply agreement for CT tubes, suggests a shift in market dynamics or the impact of the asset sale. The growth in Canvys' customized display solutions indicates continued demand for specialized display technologies across various industries. The company acknowledges global trade disruptions and geopolitical tensions as potential dampeners on customer demand and market volatility.
Comparison to Industry Standards
- NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Incorporation | Stockholders approved the Second Amended and Restated Certificate of Incorporation, increasing the aggregate number of shares for issuance to 25 million (22 million common stock, 3 million Class B common stock). | October 7, 2025 | Increases flexibility for future equity issuances and capital management. |
Stakeholder Impact
- Shareholders: Positive impact from improved net income and operating results, continued dividend payments, and increased authorized shares for potential future growth or capital actions.
- Employees: Potential positive impact from stable operations and strategic growth in GES and Canvys, but no specific details on employee-related initiatives.
- Customers: Continued provision of specialized technical expertise and engineered solutions, with new segment alignment potentially streamlining offerings.
- Creditors: Positive impact from the extension of the revolving credit facility and compliance with financial covenants, indicating financial stability.
Next Steps
- Continue manufacturing a limited quantity of ALTA CT X-ray tubes exclusively for DirectMed for approximately twelve months following January 24, 2025.
- Evaluate the impact of new FASB accounting pronouncements (ASU 2023-09, 2024-03, 2025-11) on consolidated financial statements and disclosures.
- Evaluate the future impact of the One Big Beautiful Bill Act (OBBBA) on the company's financial position.
- Address the ongoing income tax audit by the State of Illinois for fiscal years 2021-2023.
Key Dates
| Date | Description |
|---|---|
| January 24, 2025 | Company sold a substantial portion of its Healthcare business assets to DirectMed Imaging, LLC and entered into an exclusive 10-year global supply agreement. |
| May 31, 2025 | End of fiscal year 2025. |
| June 1, 2025 | Company realigned its operating segment structure from four to three segments (PMT, GES, Canvys). |
| August 4, 2025 | Annual Report on Form 10-K for fiscal year ended May 31, 2025, filed with the SEC. |
| October 7, 2025 | Stockholders approved the Second Amended and Restated Certificate of Incorporation, increasing authorized shares. Company executed a three-year extension to the PNC Credit Agreement, maturing October 7, 2028. |
| November 29, 2025 | End of the second fiscal quarter and first six months of fiscal year 2026. |
| December 2025 | FASB issued ASU 2025-11 Interim Reporting. |
| January 5, 2026 | Outstanding shares of Common Stock were 12,481,251 and Class B Common Stock were 2,036,671. |
| January 8, 2026 | Date of filing of this Quarterly Report on Form 10-Q. |
| December 15, 2024 | Effective date for FASB ASU 2023-09 for fiscal years beginning after this date. |
| December 31, 2024 | OBBBA makes 100% bonus depreciation and domestic research cost expensing permanent for fiscal years beginning after this date. |
| December 15, 2026 | Effective date for FASB ASU 2024-03 for annual reporting periods beginning after this date. |
| December 15, 2027 | Effective date for FASB ASU 2024-03 for interim reporting periods beginning after this date, and for FASB ASU 2025-11 for interim reporting periods within annual reporting periods beginning after this date. |
Recommendation
holdThe company demonstrated a strong turnaround in profitability for the six-month period, moving from a net loss to a net income, which is a positive indicator. Growth in the Green Energy Solutions and Canvys segments is encouraging, aligning with market trends. However, the PMT segment's slight decline and the decrease in cash from operating activities warrant caution. The stock has shown volatility, and while the financial improvement is notable, the overall market conditions and the company's ability to sustain this profitability, especially with ongoing geopolitical and economic risks, suggest a "hold" position. Investors should monitor the PMT segment's performance and the impact of capital expenditures on cash flow.
Keywords
Richardson Electronics, RELL, Q2 2026 Earnings, Green Energy Solutions, Power Management, Custom Display Solutions, Power and Microwave Technologies, SEC 10-Q, Financial Results, Semiconductor, Healthcare Imaging, RF and Microwave, Corporate Governance, Financial Reporting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.